AU2019903247A0 - Antisense Oligonucleotide Therapy for Cancer - Google Patents

Antisense Oligonucleotide Therapy for Cancer

Info

Publication number
AU2019903247A0
AU2019903247A0 AU2019903247A AU2019903247A AU2019903247A0 AU 2019903247 A0 AU2019903247 A0 AU 2019903247A0 AU 2019903247 A AU2019903247 A AU 2019903247A AU 2019903247 A AU2019903247 A AU 2019903247A AU 2019903247 A0 AU2019903247 A0 AU 2019903247A0
Authority
AU
Australia
Prior art keywords
cancer
antisense oligonucleotide
oligonucleotide therapy
therapy
antisense
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2019903247A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Murdoch University
Original Assignee
Murdoch University
Filing date
Publication date
Application filed by Murdoch University filed Critical Murdoch University
Publication of AU2019903247A0 publication Critical patent/AU2019903247A0/en
Priority to CA3149735A priority Critical patent/CA3149735A1/en
Priority to US17/638,041 priority patent/US20220290141A1/en
Priority to EP20859694.0A priority patent/EP4025695A4/en
Priority to PCT/AU2020/050919 priority patent/WO2021042161A1/en
Priority to AU2020341254A priority patent/AU2020341254A1/en
Priority to CN202080061841.7A priority patent/CN114341354A/en
Abandoned legal-status Critical Current

Links

AU2019903247A 2019-09-03 2019-09-03 Antisense Oligonucleotide Therapy for Cancer Abandoned AU2019903247A0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
CA3149735A CA3149735A1 (en) 2019-09-03 2020-09-02 Antisense oligonucleotide therapy for cancer
US17/638,041 US20220290141A1 (en) 2019-09-03 2020-09-02 Antisense oligonucleotide therapy for cancer
EP20859694.0A EP4025695A4 (en) 2019-09-03 2020-09-02 Antisense oligonucleotide therapy for cancer
PCT/AU2020/050919 WO2021042161A1 (en) 2019-09-03 2020-09-02 Antisense oligonucleotide therapy for cancer
AU2020341254A AU2020341254A1 (en) 2019-09-03 2020-09-02 Antisense oligonucleotide therapy for cancer
CN202080061841.7A CN114341354A (en) 2019-09-03 2020-09-02 Antisense oligonucleotide therapy for cancer

Publications (1)

Publication Number Publication Date
AU2019903247A0 true AU2019903247A0 (en) 2019-09-19

Family

ID=

Similar Documents

Publication Publication Date Title
EP3579858A4 (en) Gene therapy for haploinsufficiency
EP3678663A4 (en) Combination therapy for treating cancer
GB201903546D0 (en) Cancer treatment
EP3796891A4 (en) Therapeutic constructs for treating cancer
GB201905780D0 (en) Cancer therapy
ZA202106392B (en) Therapeutic rna for prostate cancer
EP3713576A4 (en) Methods for cancer therapy
EP3568694A4 (en) Targeted doxorubicin-gold nanoconjugates for tumor therapy
IL287554A (en) Therapeutic rna for ovarian cancer
IL287652A (en) Cancer treatment
EP3999523A4 (en) Melanophilin antisense oligonucleotides
EP3946287A4 (en) Methods for treating cancers using antisense
GB201905301D0 (en) Gene therapy
IL285466A (en) Cancer treatment
EP3423581A4 (en) Targeting microrna for cancer treatment
EP3634494A4 (en) Antisense therapies for treating cancer
IL286680A (en) Medicament for treating cancer
IL288035A (en) Cancer treatment
EP4025203A4 (en) Cancer treatment
EP4025695A4 (en) Antisense oligonucleotide therapy for cancer
EP3981473A4 (en) Therapeutic agent for cancer
AU2019903247A0 (en) Antisense Oligonucleotide Therapy for Cancer
EP3966323A4 (en) Targeted therapy
EP4101471A4 (en) Nanoparticles for cancer treatment
EP3903611A4 (en) Brassiere for radiation therapy